Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Celadon Group, Inc. (CGI) A Good Stock To Buy?

Page 1 of 2

The worries about the economic slowdown in China and the ongoing uncertainty about the path of interest-rate increases triggered several waves of equity sell-offs during the third quarter. Of course, most hedge funds and other asset managers had to stomach substantial losses during the bloody three-month period, which might have caused some to consider fleeing the U.S. equity markets. Interestingly, smaller-cap stocks registered higher losses than large-capitalization stocks during the September quarter, suggesting that institutional investors heavily discarded seemingly riskier equities amid high uncertainty and turmoil. In fact, the Russell 2000 Index lost 11.9% in the third quarter, while the Standard and Poor’s 500 benchmark declined a mere 6.4%. This article will lay out and discuss the hedge fund and institutional investor sentiment towards Celadon Group, Inc. (NYSE:CGI).

Is Celadon Group, Inc. (NYSE:CGI) the right investment to pursue these days? The best stock pickers are taking a pessimistic view. The number of long hedge fund positions retreated by 2 in recent months. CGI was in 14 hedge funds’ portfolios at the end of September. There were 16 hedge funds in our database with CGI holdings at the end of the previous quarter. At the end of this article we will also compare CGI to other stocks, including Farmer Brothers Co. (NASDAQ:FARM), Investment Technology Group (NYSE:ITG), and ANI Pharmaceuticals Inc (NASDAQ:ANIP) to get a better sense of its popularity.

Follow Celadon Group Inc
Trade (CGI) Now!

In the eyes of most stock holders, hedge funds are assumed to be slow, old financial tools of the past. While there are over 8000 funds with their doors open at the moment, Our experts hone in on the moguls of this club, approximately 700 funds. These hedge fund managers command most of the hedge fund industry’s total asset base, and by keeping an eye on their first-class picks, Insider Monkey has unearthed numerous investment strategies that have historically outrun the market. Insider Monkey’s small-cap hedge fund strategy outrun the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, we’re going to take a gander at the recent action encompassing Celadon Group, Inc. (NYSE:CGI).

What does the smart money think about Celadon Group, Inc. (NYSE:CGI)?

At Q3’s end, a total of 14 of the hedge funds tracked by Insider Monkey were long this stock, down by 13% from the second quarter. With the smart money’s capital changing hands, there exists a select group of notable hedge fund managers who were upping their stakes significantly (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Millennium Management, managed by Israel Englander, holds the biggest position in Celadon Group, Inc. (NYSE:CGI). The fund has a $7.3 million position in the stock, comprising less than 0.1% of its 13F portfolio. The second largest stake is held by Newland Capital, managed by Ken Brodkowitz and Mike Vermut, which holds an $7 million stake; 6.4% of its 13F portfolio is allocated to the stock. Remaining hedge funds and institutional investors that are bullish contain Jim Simons’s Renaissance Technologies, Alexander Mitchell’s Scopus Asset Management and Chao Ku’s Nine Chapters Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!